Skip to content

Polaryx Therapeutics, Inc. PLYX Increase Decrease In Accrued Liabilities Related Party

Increase Decrease In Accrued Liabilities Related Party at other companies

Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
-$4.18M-396%
Agrify Corporation logo
Agrify CorporationRYM
$1.17M
Agrify Corporation logo
Agrify CorporationRYM
$1.17M
Sidus Space, Inc. logo
Sidus Space, Inc.SIDU
-$825.77K-4,000%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$15.85K+45.5%
Cheniere Energy Partners logo
Cheniere Energy PartnersCQP
$0-100%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$132.59M-86.9%

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept plyx:IncreaseDecreaseInAccruedLiabilitiesRelatedParty.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's increase decrease in accrued liabilities related party.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's increase decrease in accrued liabilities related party?
Polaryx Therapeutics, Inc. (PLYX) reported increase decrease in accrued liabilities related party of $22K in Q1 2026.
How has Polaryx Therapeutics, Inc. 's increase decrease in accrued liabilities related party changed year-over-year?
Polaryx Therapeutics, Inc. 's increase decrease in accrued liabilities related party increased by 282.6% year-over-year, from $5.75K to $22K.
What does increase decrease in accrued liabilities related party mean?
This represents the change in accrued expenses specifically owed to related parties. It reflects the timing of settling obligations with entities that have a close relationship with the company.